PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-Apr-2024 Strong financial foundation: DOUGLAS Group reduces net debt by 1 billion euros and increases financial flexibility Douglas AG
15-Apr-2024 Douglas AG announces satisfaction of transaction conditions Douglas AG
12-Apr-2024 Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast Formycon AG
12-Apr-2024 Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year Formycon AG
12-Apr-2024 Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected Evolva Holding SA
12-Apr-2024 Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected Evolva Holding SA
12-Apr-2024 Straumann Group shareholders approve all proposals and elect Xiaoqun Clever-Steg and Stefan Meister as new Board Members Straumann Holding AG
11-Apr-2024 AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock AdrenoMed AG
11-Apr-2024 Sanofi announces launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for pre-exposure and post-exposure prophylaxis of rabies in all age groups Sanofi
11-Apr-2024 Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios Qinecsa
11-Apr-2024 MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis MorphoSys AG
11-Apr-2024 Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico Marinomed Biotech AG
11-Apr-2024 Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®) Formycon AG
11-Apr-2024 Gerresheimer makes solid start to the financial year 2024 Gerresheimer AG
11-Apr-2024 Medacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide Medacta Group SA
10-Apr-2024 PolyPeptide announces results of the annual General Meeting 2024 PolyPeptide Group
10-Apr-2024 AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock Adrenomed AG
10-Apr-2024 DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card DocMorris AG
10-Apr-2024 CGSI Reiterates “Buy” Rating on Modern Dental (03600HK), Ups Target Price to HK$5.88 Modern Dental Group Limited
09-Apr-2024 GSK’s Jemperli▼ (dostarlimab) is accepted for use within NHS Scotland, in line with its licence, in eligible endometrial cancer patients in first line setting GSK